This is the final time Japan gets Digimon Card Game sets earlier, but which are the best cards in Special Booster 2.5?

They tried in the television show, sort of. At the end of Season 1, doctors and nurses want to cut into the brain of the ...

Summit Therapeutics' ivonescimab shows potential in cancer treatment, but high risks and valuation concerns suggest caution.

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...

and with just one arm. The 76-year-old South African landed a hole-in-one last Friday at the Frankton Golf Centre’s driving range, sinking a shot into a super-sized hole mounted on an old ...

As a major arm of adaptive immunity, B cells and antibodies have the potential to modulate ... With further definition, these post translational mechanisms of antibody diversification that contribute ...

ACTIV-3 is a substudy of a larger, 10,000-patient trial that is putting a series of COVID-19 drugs through their paces, and Lilly’s drug is the only arm to include an antibody targeting SARS-CoV-2.

FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free ...

There has been expectation that the antibody could be made available at ... based on the selected endpoint and control arm." It also takes issue with the use of progression-free survival (PFS ...